BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Perkins G, Babasyan S, Stout AE, Freer H, Rollins A, Wimer CL, Wagner B. Intranasal IgG4/7 antibody responses protect horses against equid herpesvirus-1 (EHV-1) infection including nasal virus shedding and cell-associated viremia. Virology 2019;531:219-32. [PMID: 30928700 DOI: 10.1016/j.virol.2019.03.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Hay AN, Wagner B, Leeth CM, LeRoith T, Cecere TE, Lahmers KK, Andrews FM, Werre SR, Johnson AL, Clark CK, Pusterla N, Reed SM, Lindsay DS, Taylor S, Estell KE, Furr M, MacKay RJ, Del Piero F, Witonsky SG. Horses affected by EPM have increased sCD14 compared to healthy horses. Vet Immunol Immunopathol 2021;242:110338. [PMID: 34717126 DOI: 10.1016/j.vetimm.2021.110338] [Reference Citation Analysis]
2 Goodrich EL, McLean A, Guarino C. A Pilot Serosurvey for Selected Pathogens in Feral Donkeys (Equus asinus). Animals (Basel) 2020;10:E1796. [PMID: 33023217 DOI: 10.3390/ani10101796] [Reference Citation Analysis]
3 Larson EM, Wagner B. Viral infection and allergy - What equine immune responses can tell us about disease severity and protection. Mol Immunol 2021;135:329-41. [PMID: 33975251 DOI: 10.1016/j.molimm.2021.04.013] [Reference Citation Analysis]
4 Kydd JH, Lunn DP, Osterrieder K. Report of the Fourth International Havemeyer Workshop on Equid Herpesviruses (EHV) EHV‐1, EHV‐2 and EHV‐5. Equine Vet J 2019;51:565-8. [DOI: 10.1111/evj.13141] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bannai H, Takahashi Y, Ohmura H, Ebisuda Y, Mukai K, Kambayashi Y, Nemoto M, Tsujimura K, Ohta M, Raidal S, Padalino B. Decreased Virus-Neutralizing Antibodies Against Equine Herpesvirus type 1 In Nasal Secretions of Horses After 12-hour Transportation. J Equine Vet Sci 2021;103:103665. [PMID: 34281635 DOI: 10.1016/j.jevs.2021.103665] [Reference Citation Analysis]
6 Schnabel CL, Babasyan S, Rollins A, Freer H, Wimer CL, Perkins GA, Raza F, Osterrieder N, Wagner B. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease. J Virol 2019;93:e01011-19. [PMID: 31462575 DOI: 10.1128/JVI.01011-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kydd JH, Hannant D, Robinson RS, Bryant N, Osterrieder N. Vaccination of foals with a modified live, equid herpesvirus-1 gM deletion mutant (RacHΔgM) confers partial protection against infection. Vaccine 2020;38:388-98. [PMID: 31629571 DOI: 10.1016/j.vaccine.2019.09.106] [Reference Citation Analysis]
8 Oladunni FS, Horohov DW, Chambers TM. EHV-1: A Constant Threat to the Horse Industry. Front Microbiol 2019;10:2668. [PMID: 31849857 DOI: 10.3389/fmicb.2019.02668] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]